コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 case reported on entecavir induced lichenoid drug eruption.
2 d histopathological findings consistent with drug eruption.
3 r reflect the dermatologic classification of drug eruptions.
4 d to mild, uncomplicated exanthems and fixed drug eruptions.
5 treatment outcomes of patients with purpuric drug eruptions.
6 been previously reported to cause lichenoid drug eruptions.
7 nisms underlying pegylated IFN-alpha-induced drug eruptions.
8 , and toxic epidermal necrolysis), 2 months (drug eruption and eczematous dermatitis), 4 months (lich
9 001-related serious adverse events (atypical drug eruption and thrombocytopenia) and two in the tenof
12 lpha in the pathogenesis of psoriasis, fixed drug eruption, atopic and allergic contact dermatitis.
14 ash with skin biopsy results compatible with drug eruption determined by clinicopathologic correlatio
15 [HR], 0.695; 95% CI, 0.602-0.803; P < .001), drug eruption (HR, 0.755; 95% CI, 0.635-0.897; P = .001)
16 , Stevens-Johnson syndrome (IC(025) = 0.41), drug eruption (IC(025) = 0.11), and eczematous dermatiti
17 lly thought to be associated with eczematous drug eruptions (ie, eczematous and interface dermatitis)
21 eatening drug reaction, developed a systemic drug eruption, or had to prematurely stop triple therapy
23 ; 12 female and 2 male) and 18 with purpuric drug eruptions with pustules (mean [SD] age, 64 [11] yea